Fatal Tumor Lysis Syndrome Induced by Pembrolizumab in Advanced Renal Pelvis Cancer
This case highlights a fatal TLS episode after pembrolizumab. Given its poor prognosis, blood monitoring and prophylaxis are warranted in intermediate-risk patients, particularly when multiple non-renal risk factors are present.
Authors
- Hirotaka Asakura
- Takayuki Asakura (ORCID: https://orcid.org/0009-0006-7014-1783)
- Toshiaki Shinojima (ORCID: https://orcid.org/0000-0001-5005-5366)
- Shinnosuke Hiruta
Institutions
- Saitama Medical University (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1002/iju5.70097
- Citations
- 1
- Primary Topic
- Methemoglobinemia and Tumor Lysis Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.52